126 related articles for article (PubMed ID: 8204352)
1. Serum concentrations of cytokines in patients with Hodgkin's disease.
Blay JY; Farcet JP; Lavaud A; Radoux D; Chouaïb S
Eur J Cancer; 1994; 30A(3):321-4. PubMed ID: 8204352
[TBL] [Abstract][Full Text] [Related]
2. Serum interleukin 6 levels are elevated in lymphoma patients and correlate with survival in advanced Hodgkin's disease and with B symptoms.
Kurzrock R; Redman J; Cabanillas F; Jones D; Rothberg J; Talpaz M
Cancer Res; 1993 May; 53(9):2118-22. PubMed ID: 8481913
[TBL] [Abstract][Full Text] [Related]
3. Cytokine production (IL-1 alpha, IL-1 beta, and TNF alpha) and endothelial cell activation (ELAM-1 and HLA-DR) in reactive lymphadenitis, Hodgkin's disease, and in non-Hodgkin's lymphomas. An immunocytochemical study.
Ruco LP; Pomponi D; Pigott R; Stoppacciaro A; Monardo F; Uccini S; Boraschi D; Tagliabue A; Santoni A; Dejana E
Am J Pathol; 1990 Nov; 137(5):1163-71. PubMed ID: 1700619
[TBL] [Abstract][Full Text] [Related]
4. Clinical correlates of elevated serum levels of interleukin 6 in patients with untreated Hodgkin's disease.
Seymour JF; Talpaz M; Hagemeister FB; Cabanillas F; Kurzrock R
Am J Med; 1997 Jan; 102(1):21-8. PubMed ID: 9209197
[TBL] [Abstract][Full Text] [Related]
5. Increased levels of circulating interleukin-6 in patients with Hodgkin's disease.
Gause A; Scholz R; Klein S; Jung W; Diehl V; Tesch H; Hasenclever D; Pfreundschuh M
Hematol Oncol; 1991; 9(6):307-13. PubMed ID: 1748397
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-1, interleukin-2, interleukin-4, interleukin-6, tumor necrosis factor alpha, and interferon-gamma levels in sera from patients with scleroderma.
Needleman BW; Wigley FM; Stair RW
Arthritis Rheum; 1992 Jan; 35(1):67-72. PubMed ID: 1731816
[TBL] [Abstract][Full Text] [Related]
7. Plasma levels of tumour necrosis factor and its soluble receptors correlate with clinical features and outcome of Hodgkin's disease patients.
Warzocha K; Bienvenu J; Ribeiro P; Moullet I; Dumontet C; Neidhardt-Berard EM; Coiffier B; Salles G
Br J Cancer; 1998 Jun; 77(12):2357-62. PubMed ID: 9649158
[TBL] [Abstract][Full Text] [Related]
8. Serum cytokine levels correlate with clinical parameters in Hodgkin's disease.
Gorschlüter M; Bohlen H; Hasenclever D; Diehl V; Tesch H
Ann Oncol; 1995 May; 6(5):477-82. PubMed ID: 7545429
[TBL] [Abstract][Full Text] [Related]
9. [Proinflammatory cytokines in inactive lupus erythematosus patients].
Lesiak A; Sysa-Jedrzejowska A; Narbutt J; Lukamowicz J; Robak E; Wozniacka A
Przegl Lek; 2005; 62(9):838-42. PubMed ID: 16541713
[TBL] [Abstract][Full Text] [Related]
10. Increased levels of circulating cytokines in patients with untreated Hodgkin's disease.
Gause A; Keymis S; Scholz R; Schobert I; Jung W; Diehl V; Pohl C; Pfreundschuh M
Lymphokine Cytokine Res; 1992 Apr; 11(2):109-13. PubMed ID: 1581417
[TBL] [Abstract][Full Text] [Related]
11. [Measurement of five cytokines in the serum of malignant lymphoma patients].
Zhu H; Wang Y; Han X
Zhonghua Xue Ye Xue Za Zhi; 1998 Feb; 19(2):85-8. PubMed ID: 10921109
[TBL] [Abstract][Full Text] [Related]
12. The clinical significance of cytokines and soluble forms of membrane-derived activation antigens in the serum of patients with Hodgkin's disease.
Gause A; Jung W; Keymis S; Schobert I; Scholz R; Schmits R; Diehl V; Pohl C; Hasenclever D; Pfreundschuh M
Leuk Lymphoma; 1992 Aug; 7(5-6):439-47. PubMed ID: 1283546
[TBL] [Abstract][Full Text] [Related]
13. Comparison of serum NO, TNF-alpha, IL-1beta, sIL-2R, IL-6 and IL-8 levels with grades of retinopathy in patients with diabetes mellitus.
Doganay S; Evereklioglu C; Er H; Türköz Y; Sevinç A; Mehmet N; Savli H
Eye (Lond); 2002 Mar; 16(2):163-70. PubMed ID: 11988817
[TBL] [Abstract][Full Text] [Related]
14. Angiogenic molecules in Hodgkin's disease: results from sequential serum analysis.
Passam FH; Alexandrakis MG; Moschandrea J; Sfiridaki A; Roussou PA; Siafakas NM
Int J Immunopathol Pharmacol; 2006; 19(1):161-70. PubMed ID: 16569354
[TBL] [Abstract][Full Text] [Related]
15. Serum IL-1beta, sIL-2R, IL-6, IL-8 and TNF-alpha in schizophrenic patients, relation with symptomatology and responsiveness to risperidone treatment.
Erbağci AB; Herken H; Köylüoglu O; Yilmaz N; Tarakçioglu M
Mediators Inflamm; 2001 Jun; 10(3):109-15. PubMed ID: 11545247
[TBL] [Abstract][Full Text] [Related]
16. Correlation of serum IL-2, IL-6 and IL-10 levels with International Prognostic Index in patients with aggressive non-Hodgkin's lymphoma.
Aydin F; Yilmaz M; Ozdemir F; Kavgaci H; Yavuz MN; Yavuz AA
Am J Clin Oncol; 2002 Dec; 25(6):570-2. PubMed ID: 12478000
[TBL] [Abstract][Full Text] [Related]
17. Enhanced generation of interleukins 1 beta and 6 may contribute to the cachexia of chronic disease.
Cederholm T; Wretlind B; Hellström K; Andersson B; Engström L; Brismar K; Scheynius A; Forslid J; Palmblad J
Am J Clin Nutr; 1997 Mar; 65(3):876-82. PubMed ID: 9062543
[TBL] [Abstract][Full Text] [Related]
18. The cytokines IL-1beta and IL-1 receptor antagonist, IL-2 and IL-2 soluble receptor-alpha, IL-6 and IL-6 soluble receptor, TNF-alpha and TNF soluble receptor I, and IL10 in drained and systemic blood after major orthopaedic surgery.
Krohn CD; Reikerås O; Aasen AO
Eur J Surg; 1999 Feb; 165(2):101-9. PubMed ID: 10192566
[TBL] [Abstract][Full Text] [Related]
19. Increased serum levels of interleukin-9 correlate to negative prognostic factors in Hodgkin's lymphoma.
Fischer M; Bijman M; Molin D; Cormont F; Uyttenhove C; van Snick J; Sundström C; Enblad G; Nilsson G
Leukemia; 2003 Dec; 17(12):2513-6. PubMed ID: 14562126
[TBL] [Abstract][Full Text] [Related]
20. Levels of serum IL-1beta, IL-2, IL-8 and tumor necrosis factor-alpha in patients with unstable angina pectoris.
Ozeren A; Aydin M; Tokac M; Demircan N; Unalacak M; Gurel A; Yazici M
Mediators Inflamm; 2003 Dec; 12(6):361-5. PubMed ID: 14668096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
